REPERFUSION INJURY
Clinical trials for REPERFUSION INJURY explained in plain language.
Never miss a new study
Get alerted when new REPERFUSION INJURY trials appear
Sign up with your email to follow new studies for REPERFUSION INJURY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to limit heart damage after attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe type of heart attack (STEMI) and are getting a procedure to open the blocked artery. Participants receive either Xolatryp or a placebo as a one-time IV infusion over 6 hours. The study checks if the drug …
Matched conditions: REPERFUSION INJURY
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated May 17, 2026 08:51 UTC
-
Chilling the heart: could cold therapy be the key to healing after a heart attack?
Disease control Recruiting nowThis study is testing a new approach to reduce heart damage during a heart attack. When a heart artery is blocked, restoring blood flow can sometimes cause additional injury. Researchers are cooling the heart's arteries with a cold saline solution right after opening the blockage…
Matched conditions: REPERFUSION INJURY
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated May 01, 2026 15:59 UTC